(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HEMLIBRA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

HEMLIBRA

ST13

US500000087449931

Class

41, 44

Filing

87449931

Registration

5722898

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

06/24/2025

Trademark type

Combined

Nice classes

41, 44

Filing date

05/15/2017

Registration date

04/09/2019

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/23/2025

Last transaction

06/24/2025

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

11/16/2017

First use in commerce

11/16/2017

Drawing code

3

Owner type

99

Owner location

Tokyo, JP

Examiner

MARTIN, LIEF

Current location

Historical data usage

Mark description

The mark consists of the word "HEMLIBRA" with three curved stacked lines above the letter "H".

Holders and representatives

Holders

C. K. (pessoa física)

Representatives

Mainak H. Mehta Procopio, Cory, Hargreaves & Savitch LLP

Technical classification

Nice Classes

Class 41Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

Providing educational classesseminarsworkshopssymposiums and conferences and training services in the medical field

Class 44

Providing medical information on pharmaceuticals and other medical information

Publications

History of USPTO decisions and trademark events.

29 publications found

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

06/23/2025

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

06/23/2025

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

06/23/2025

E815

TEAS SECTION 8 & 15 RECEIVED

02/26/2025

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

04/09/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/09/2019

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/05/2019

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/04/2019

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/15/2019

IUAF

USE AMENDMENT FILED

02/14/2019

EISU

TEAS STATEMENT OF USE RECEIVED

02/14/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/21/2018

EX2G

SOU EXTENSION 2 GRANTED

11/20/2018

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/20/2018

EXT2

SOU EXTENSION 2 FILED

11/13/2018

EEXT

SOU TEAS EXTENSION RECEIVED

11/13/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/15/2018

EX1G

SOU EXTENSION 1 GRANTED

05/11/2018

EXT1

SOU EXTENSION 1 FILED

05/11/2018

EEXT

SOU TEAS EXTENSION RECEIVED

05/11/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/14/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/19/2017

PUBO

PUBLISHED FOR OPPOSITION

09/19/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/30/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/14/2017

DOCK

ASSIGNED TO EXAMINER

08/14/2017

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/20/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/19/2017

NWAP

NEW APPLICATION ENTERED

05/18/2017

Continuous trademark protection

Get notified about every new filing that threatens HEMLIBRA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.